Age at Onset and Frequency of Clinical Signs and Symptoms in Patients with Aadc Deficiency: A Systematic Literature Review

Author(s)

Bakidou A1, Werner C2, Buesch K3
1PTC Therapeutics, Gothenburg, Sweden, 2PTC Therapeutics, Frankfurt, Germany, 3PTC Therapeutics, Steinhausen, Switzerland

OBJECTIVES: Aromatic L-Amino acid Decarboxylase (AADC) deficiency is a rare disorder of monoamine synthesis. A few hundred cases have been reported globally with a varied phenotypic severity. There is a limited understanding of the clinical course and burden of AADC deficiency. This literature review and case report data analysis aimed to determine the timing of the onset and frequency of clinical signs and symptoms in patients with AADC deficiency.

METHODS: A systematic literature search was conducted identifying all case reports of series of patients with AADC deficiency who reported the age at onset of clinical signs and symptoms. Demographics and clinical data were extracted, categorized (developmental delays, movement disorders, tone regulation, autonomic function problems, cardiovascular/gastrointestinal/endocrine/respiratory problems and others), and classified by age of onset of clinical signs and symptoms.

RESULTS: From the 29 studies that met the inclusion criteria, 66 (50% male) AADC deficient patients, with mean age at diagnosis of 4,4 years (SD 5,3 years; 23 % missing data), were included in the analysis. For 29% of the patients, the first clinical signs/symptoms were reported as early as during the first 30 days after birth. By the age of 2 years, 94% of patients had experienced at least 1 of the clinical signs and symptoms/events of the disease; with 13% and 28% having experienced the 6 main signs/symptoms by 2 years and 6 years of age, respectively. Over the observation period, all patients experienced ≥1 sign or symptom deemed to contribute to the burden of AADC deficiency; movement disorders (98%), tone regulation (94%), developmental delays (83%), and autonomic dysfunction (77%) were most frequently reported.

CONCLUSIONS: AADC deficiency is associated with a high disease burden, regardless of age of onset of clinical symptoms. The accumulation of the disease burden across lifetime reflects the progression of the disease.

Conference/Value in Health Info

2020-11, ISPOR Europe 2020, Milan, Italy

Value in Health, Volume 23, Issue S2 (December 2020)

Code

PRO8

Topic

Clinical Outcomes

Topic Subcategory

Clinical Outcomes Assessment, Relating Intermediate to Long-term Outcomes

Disease

Generics, Neurological Disorders, Pediatrics, Rare and Orphan Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×